Rebecca Levy, MD, PhD, Instructor, Child Neurology and Neurogenomics, Lucile Packard Children’s Hospital at Stanford University
Understanding what strengths and challenges may happen for a disorder can help families and their medical providers plan, screen, and treat individuals more effectively.
We were honoured to collaborate with TSA as well as families and individuals with CRD around the world to learn whether they experienced issues in development, as well as symptoms involving mood, learning, and the nervous system.
Many individuals with CRD had delays in learning to walk and talk, as well as other developmental milestones. They also commonly reported neuropsychiatric symptoms such as imbalance, incoordination, difficulty with chewing, learning or cognitive disability, seizures, and symptoms associated with autism spectrum disorder.
Whether or not an individual had long QT syndrome did not affect the risk of developmental or neuropsychiatric symptoms, so in CRD this risk may be related to brain-specific and not heart-related impacts of the CACNA1C gene.
We are continuing to recruit for this cohort, please contact TSA for more information.
View the non-peer-reviewed version of this work.
Help us fund more research
Your donations help us engage with more people in the scientific community.
Your contribution will help:
- raise awareness to drive research and clinical development
- enhance scientific understanding
- reduce the isolation faced by families
With your help, treatment and a cure for future generations is closer to being found.
See other ways that you can support us.